Synthetic oligosaccharide subunits of the Psl exopolysaccharide of pseudomonas aeruginosa and uses thereof

US10870710B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10870710-B2
Application numberUS-201816219199-A
CountryUS
Kind codeB2
Filing dateDec 13, 2018
Priority dateMay 14, 2013
Publication dateDec 22, 2020
Grant dateDec 22, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

This disclosure relates to synthetic oligosaccharide subunits of the Pseudomonas exosaccharide Psi and uses thereof, e.g., for epitope mapping of anti-Psl antibodies, for identification of anti-Psl antibodies, and for use as vaccines. In one aspect a synthetic oligosaccharide subunit of a Pseudomonas aeruginosa Psl oligosaccharide is provided, comprising the trisaccharide of formula I.

First claim

Opening claim text (preview).

What is claimed is: 1. A method comprising (a) reacting a thiomannosyl donor 7 with acceptor saccharide 10 to form disaccharide 13, and then partially deprotecting disaccharide 13 to form disaccharide 14: (b) reacting disaccharide 14 and with thiomannoside 8 to form trisaccharide 15 then partially deprotecting the trisaccharide to form compound 16, then reacting compound 16 with CC 1 3 CN, and Cs 2 CO 3 , in dichloromethane to form the trichloroacetimidate trisaccharide 17: and (c) reacting the trichloroacetimidate trisaccharide 17 with compound 12 in the presence of trimethylsilyl trifluoromethanesulfonate and dichloromethane at −30° C. to form a linear tetrasaccharide 18 then partially deprotecting linear tetrasaccharide 18 with hydrofluoric acid in pyridine to form the linear tetrasaccharide 19: and wherein Nap is 2-methylnaphthyl, Ph is a phenyl group, Bn is a benzyl group, Bz is a benzoyl group, All is allyl ether, and TBS is t-butyldimethylsilyl. 2. The method of claim 1 , further comprising deprotecting the linear tetrasaccharide 19 to form tetrasaccharide 3: 3. The method of claim 1 , further comprising (d) reacting the linear tetrasaccharide 19 with compound 9 in the presence of trimethylsilyl trifluoromethanesulfonate and dichloromethane to form a pentasaccharide 20 then partially deprotecting pentasaccharide 20 to form a pentasaccharide 21: wherein Ac is an acetyl group. 4. The method of claim 3 , further comprising deprotecting the pentasaccharide 20 to form a pentasaccharide 2: 5. The method of claim 3 , further comprising (e) reacting the pentasaccharide 21 with compound 11 in the presence of N-iodosuccinimide, trimethylsilyl trifluoromethanesulfonate and dichloromethane to form a hexasaccharide 22 then partially deprotecting the hexasaccharide 22 with hydrofluoric acid in pyridine to form a hexasaccharide 6: wherein Et is an ethyl group. 6. The method of claim 5 , further comprising deprotecting compound the hexasaccharide 6 to form a hexasaccharide 4: 7. The method of claim 5 , further comprising: (f) partially deprotecting the trisaccharide 15 in the presence of hydrofluoric acid in pyridine to form a trisaccharide 23 and reacting the trisaccharide 23 with compound 9 in the presence of trimethylsilyl trifluoromethanesulfonate and dichloromethane to form a tetrasaccharide 24 then reacting the tetrasaccharide 24 in the presence of (Ph 3P ) 3 RhC1, N,N-disopropylethylamine in toluene, followed by HgO, HgC 1 2 , in acetone/H2O to form a tetrasaccharide 25, then deprotecting the tetrasaccharide 25 with 2,2,2-trifluoro-N-phenylacetimidoyl chloride, 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) in dichloromethane to form a tetrasaccharide 5: (g) reacting hexasaccharide 6 with tetrasaccharide 5 in the presence of trimethylsilyl trifluoromethanesulfonate and dichloromethane to form a decasaccharide 26 then deprotecting decasaccharide 26 to form compound 1:

Assignees

Inventors

Classifications

  • Bacteria · CPC title

  • for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites · CPC title

  • from Pseudomonadaceae (F) · CPC title

  • Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof · CPC title

  • Immunostimulants · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10870710B2 cover?
This disclosure relates to synthetic oligosaccharide subunits of the Pseudomonas exosaccharide Psi and uses thereof, e.g., for epitope mapping of anti-Psl antibodies, for identification of anti-Psl antibodies, and for use as vaccines. In one aspect a synthetic oligosaccharide subunit of a Pseudomonas aeruginosa Psl oligosaccharide is provided, comprising the trisaccharide of formula I.
Who is the assignee on this patent?
Medlmmune Ltd, Univ Georgia, Medimmune Ltd
What technology area does this patent fall under?
Primary CPC classification G01N33/56911. Mapped technology areas include Physics.
When was this patent published?
Publication date Tue Dec 22 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).